Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Medicenna Therapeutics Corp. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q4 2021
- Shares held
- 4.28M
- −159.4K (−3.6%) vs. Q4 2021
- Total value
- $5.47M
- −$1.95M (−26.3%) vs. Q4 2021
- New holders
- 2
- 7 more added
- Sold out
- 5
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDNAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $200.4K |
| Q3 2024 | 1 | $175.0K |
| Q2 2024 | 1 | $145.0K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $40.9K |
| Q3 2023 | 26 | $2.45M |
| Q2 2023 | 28 | $4.75M |
| Q1 2023 | 28 | $6.25M |
| Q4 2022 | 28 | $4.75M |
| Q3 2022 | 29 | $9.67M |
| Q2 2022 | 19 | $5.41M |
| Q1 2022 | 20 | $5.47M |
| Q4 2021 | 23 | $7.42M |
| Q3 2021 | 25 | $8.66M |
| Q2 2021 | 26 | $15.4M |
| Q1 2021 | 31 | $22.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Medicenna Therapeutics Corp.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 2,272,700 | $2.91M | 1.05% | +58,400+2.6% | Added |
| Worth Venture Partners, LLC | 571,489 | $727.0K | 0.34% | +58,400+11.4% | Added |
| Verition Fund Management LLC | 539,051 | $685.0K | 0.01% | 00.0% | Unchanged |
| Sigma Planning Corp | 200,300 | $256.0K | 0.01% | +60,250+43.0% | Added |
| ACT Capital Management, LLC | 152,500 | $195.0K | 0.21% | 00.0% | Unchanged |
| Letko, Brosseau & Associates Inc | 100,000 | $128.0K | 0.00% | 00.0% | Unchanged |
| Intact Investment Management Inc. | 73,900 | $117.0K | 0.00% | −285,900−79.5% | Reduced |
| Tocqueville Asset Management L.P. | 88,000 | $112.0K | 0.00% | 00.0% | Unchanged |
| McKinley Carter Wealth Services, Inc. | 79,259 | $101.0K | 0.01% | +66,665+529.3% | Added |
| Rathbone Brothers plc | 40,000 | $53.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 39,700 | $51.0K | 0.00% | −59,300−59.9% | Reduced |
| Geode Capital Management, LLC | 34,144 | $43.0K | 0.00% | +6,511+23.6% | Added |
| Susquehanna International Group, LLP | 20,861 | $26.0K | 0.00% | +20,861 | New |
| Patriot Financial Group Insurance Agency, LLC | 17,900 | $23.0K | 0.00% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 12,915 | $17.0K | 0.01% | −1,000−7.2% | Reduced |
| Royal Bank of Canada | 11,831 | $15.0K | 0.00% | +978+9.0% | Added |
| Morgan Stanley | 3,819 | $5.00K | 0.00% | −3,521−48.0% | Reduced |
| Toronto Dominion Bank | 1,875 | $3.00K | 0.00% | +1,875 | New |
| Steward Partners Investment Advisory, LLC | 1,666 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 22,176 | – | – | +500+2.3% | Added |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −65,878−100.0% | Sold out |
| K.J. Harrison & Partners Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,872−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,882−100.0% | Sold out |
| TAP Consulting, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |